Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial

Journal:

The Lancet Oncology

Published:

2026-01-16

DOI:

10.1016/s1470-2045(25)00662-x

Affiliations:

14

Authors:

22

Go to article

Institutions	Authors	Share
NUS National University Hospital (NUH), Singapore	6.000000	0.27
National University of Singapore (NUS), Singapore	3.666667	0.17
National University Cancer Institute (NCIS), Singapore	3.333333	0.15
National Cancer Centre Singapore (NCCS), Singapore	3.000000	0.14
Chung-Ang University Hospital (CAUH), South Korea	1.000000	0.05
Yonsei Cancer Hospital, South Korea	1.000000	0.05
Severance Hospital, Yonsei University, South Korea	1.000000	0.05
Samsung Medical Center (SMC), South Korea	1.000000	0.05
Soonchunhyang University (SCH), South Korea	1.000000	0.05
Seoul National University (SNU), South Korea	1.000000	0.05

Interested in Oncology and Carcinogenesis?